COVID-19 testing demand delays Quest's turnaround time
July 7, 2020 -- Demand for COVID-19 testing continues to increase, causing further turnaround time delays for Quest Diagnostics, according to a statement released by the firm on July 6.
Structo to produce nasal testing swabs
July 7, 2020 -- 3D printing startup Structo of Singapore has pivoted from solely producing dental models to also manufacturing presterilized nasopharyngeal swabs to aid in COVID-19 testing.
Asuragen wins CE Mark for spinal muscular atrophy test
July 7, 2020 -- Asuragen has secured the CE Mark for its diagnostic kit for spinal muscular atrophy.
Natera touts data supporting personalized ctDNA testing
July 7, 2020 -- Natera is highlighting clinical data that supports the efficacy of personalized circulating tumor DNA (ctDNA) testing for oligometastatic colorectal cancer.
Companion diagnostics survive COVID-19 with small nick
July 6, 2020 -- The COVID-19 crisis has had a slightly negative, but not critical, impact on the market for companion diagnostics, according to a new market report from market research firm Kalorama Information.  Discuss
FDA alerts labs to false positives with BD coronavirus reagents
July 6, 2020 -- The U.S. Food and Drug Administration (FDA) has alerted labs and healthcare providers to the risk of false positives with SARS-CoV-2 reagents manufactured by Becton Dickinson (BD).
Mammaprint maker settles Medicare fraud lawsuit for $8M
July 6, 2020 -- The maker of a popular genetic test that analyzes a patient's risk of breast cancer recurrence has agreed to pay an $8.25 million settlement for an alleged scheme to defraud Medicare.
Thermo Fisher Scientific sees Q2 revenue boost from COVID-19 testing
July 6, 2020 -- Thermo Fisher Scientific saw a 10% increase in revenue in its second quarter.
Centogene partners with Oesis on COVID-19 testing in schools
July 6, 2020 -- Centogene is partnering with school consortium Oesis Network to provide COVID-19 reverse transcription polymerase chain reaction testing for U.S. students.
NIH funds research to improve genomics for Black kids
July 6, 2020 -- The Children's Hospital of Philadelphia is one of the recipients of a multimillion-dollar grant from the U.S. National Institutes of Health (NIH) for projects that use genomics to improve risk assessment. The hospital will use the funding to improve genetic risk assessment for Black children and their families.